DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,330,237 | $115,451,000 | 58.64% |
| EcoR1 Capital, LLC | 3,316,407 | $52,233,000 | 5.28% |
| RTW INVESTMENTS, LP | 6,152,103 | $96,896,000 | 5.18% |
| BRIDGER MANAGEMENT, LLC | 4,171,065 | $65,694,000 | 5.16% |
| UNIVERSITY OF NOTRE DAME DU LAC | 759,949 | $11,969,000 | 2.72% |
| ACUTA CAPITAL PARTNERS, LLC | 384,500 | $6,056,000 | 2.15% |
| BVF INC/IL | 1,223,925 | $19,277,000 | 2.10% |
| RA Capital Management | 2,456,669 | $38,693,000 | 2.08% |
| Sio Capital Management, LLC | 526,059 | $8,285,000 | 2.00% |
| Ghost Tree Capital, LLC | 235,000 | $3,701,000 | 0.77% |